ASHTON MEDICAL GROUP
CHAPEL STREET, ASHTON-UNDER-LYNE
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 18 | 20 | 90.0% | |
| HF 4 | 2011 | 19 | 23 | 82.6% | |
| HF 4 | 2012 | 13 | 15 | 86.7% | |
| HF 4 | 2013 | 15 | 18 | 83.3% | |
| HF004 | 2014 | 2 | 2 | 100.0% | |
| HF004 | 2015 | 2 | 2 | 100.0% | |
| HF004 | 2016 | 3 | 3 | 100.0% | |
| HF004 | 2017 | 19 | 24 | 79.2% | |
| HF004 | 2018 | 17 | 20 | 85.0% | |
| HF004 | 2019 | 65 | 71 | 91.5% | |
| HF004 | 2020 | 30 | 36 | 83.3% | |
| HF006 | 2021 | 81 | 91 | 89.0% | |
| HF006 | 2022 | 77 | 83 | 92.8% | |
| HF006 | 2023 | 130 | 136 | 95.6% |
